Wellington Partners Venture Capital GmbH

About The Fund

Wellington Partners Venture Capital GmbH is a venture capital firm headquartered in Munich, Germany, with a focus on equity investments within a broad spectrum of industries. They are particularly interested in the fields of Software, IT, Media, Education, BioTech, Business Solutions, Hardware, Energy, Entertainment, IoT, CleanTech, A.I., Gaming, Material Science, Medical Devices, FoodTech, Healthcare, Investment Management, Life Science, Mobile and Consumer. Established with over 24 years of experience, Wellington Partners specialise in Seed, Startup, Early Stage, and Expansion investments, operating with a venture capital fund type. They manage assets totaling approximately 800 million euros and offer financing solutions ranging from 200,000 to 241 million euros. Wellington Partners' investment thesis is stage agnostic, covering seed to growth stages. They possess a diversified portfolio and take pride in supporting entrepreneurs with groundbreaking technologies in scaling their businesses and achieving global leadership. Their interest in life sciences drives them to partner with companies involved in Therapeutics, Medical Devices, Diagnostics, Digital Health, and Industrial Biotechnology. With 58 life science investments and 27 successful exits, including IPOs and trade sales, their commitment to healthcare innovation is evident. Further, they operate from multiple locations, including Munich, London, and Zurich, to tap into a wider European entrepreneurial ecosystem. As their largest fund, WPLS V, closed at over 210 million euros, they have significantly expanded their capacity to support the growth of startups in Europe. Their portfolio comprises companies like Polares Medical, Oxford Immunotec, Aignostics, and MTM Laboratories, reflecting their dedication to disruptive and innovative healthcare solutions. Wellington Partners also emphasize personal relations with their investees, viewing their success as a mutual growth journey.